JP2021505241A5 - - Google Patents

Download PDF

Info

Publication number
JP2021505241A5
JP2021505241A5 JP2020530311A JP2020530311A JP2021505241A5 JP 2021505241 A5 JP2021505241 A5 JP 2021505241A5 JP 2020530311 A JP2020530311 A JP 2020530311A JP 2020530311 A JP2020530311 A JP 2020530311A JP 2021505241 A5 JP2021505241 A5 JP 2021505241A5
Authority
JP
Japan
Prior art keywords
days
patent document
international
prior
documents cited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020530311A
Other languages
English (en)
Other versions
JP2021505241A (ja
JP7296084B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/059579 external-priority patent/WO2019111132A1/en
Publication of JP2021505241A publication Critical patent/JP2021505241A/ja
Publication of JP2021505241A5 publication Critical patent/JP2021505241A5/ja
Application granted granted Critical
Publication of JP7296084B2 publication Critical patent/JP7296084B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

少なくとも約48時間、少なくとも約3日、少なくとも約4日、少なくとも約5日、少なくとも約6日、少なくとも約7日または少なくとも約8日にわたって胃の中に治療薬または診断薬および/または電子デバイスを保持する能力を有する胃滞留性製品が望ましい。
この出願の発明に関連する先行技術文献情報としては、以下のものがある(国際出願日以降国際段階で引用された文献及び他国に国内移行した際に引用された文献を含む)。
(先行技術文献)
(特許文献)
(特許文献1) 米国特許出願公開第2015/342877号明細書
(特許文献2) 国際公開第2018/102799号
JP2020530311A 2017-12-04 2018-12-03 長時間作用型胃滞留システム Active JP7296084B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762594257P 2017-12-04 2017-12-04
US62/594,257 2017-12-04
US201862681525P 2018-06-06 2018-06-06
US62/681,525 2018-06-06
PCT/IB2018/059579 WO2019111132A1 (en) 2017-12-04 2018-12-03 Long acting gastric residence system

Publications (3)

Publication Number Publication Date
JP2021505241A JP2021505241A (ja) 2021-02-18
JP2021505241A5 true JP2021505241A5 (ja) 2021-11-18
JP7296084B2 JP7296084B2 (ja) 2023-06-22

Family

ID=64902152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020530311A Active JP7296084B2 (ja) 2017-12-04 2018-12-03 長時間作用型胃滞留システム

Country Status (4)

Country Link
US (2) US11547839B2 (ja)
EP (1) EP3720537A1 (ja)
JP (1) JP7296084B2 (ja)
WO (1) WO2019111132A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7085473B2 (ja) 2015-10-23 2022-06-16 リンドラ セラピューティクス, インコーポレイティド 治療薬の持続放出用の胃内滞留システム及びその使用方法
EP4302817A3 (en) 2015-12-08 2024-02-21 Lyndra Therapeutics, Inc. Geometric configurations for gastric residence systems
AU2017336154B2 (en) 2016-09-30 2023-11-09 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
EP3720537A1 (en) * 2017-12-04 2020-10-14 Clexio Biosciences Ltd. Long acting gastric residence system
US11511093B2 (en) * 2019-10-11 2022-11-29 Wonkwang University Center for Industry Academy Cooperation Gastroretentive drug delivery device having expandable structure and manufacturing method therefor
EP4204064A1 (en) * 2020-08-30 2023-07-05 Teva Pharmaceutical Industries Ltd. Devices for regio-specific release of carried drug at ileocecal region
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions
CN115518052B (zh) * 2022-09-22 2024-01-02 江苏集萃新型药物制剂技术研究所有限公司 胃滞留制剂及其制备方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1318259A (en) 1919-10-07 Resilient wheel
AU449029B2 (en) 1969-08-28 1974-04-17 Commonwealth Scientific And Industrial Research Organisation Device for administration to ruminants
US4220153A (en) 1978-05-08 1980-09-02 Pfizer Inc. Controlled release delivery system
JPS6226215A (ja) 1985-05-10 1987-02-04 メルク エンド カムパニ− インコ−ポレ−テツド 一定に制御した時間内胃中に保持できる薬剤移送装置
CA1273872A (en) 1985-05-10 1990-09-11 Larry J. Caldwell Drug delivery device which can be retained in the stomach for a controlled period of time
US4735804A (en) 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US5002772A (en) 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
JPH03163011A (ja) 1989-08-31 1991-07-15 Yamanouchi Pharmaceut Co Ltd 胃内滞留デバイス
IT1282650B1 (it) 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
IL133196A0 (en) 1999-11-29 2001-03-19 Yissum Res Dev Co Gastroretentive controlled release pharmaceutical dosage forms
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
DE60123384T2 (de) 2000-02-04 2007-08-02 DepoMed, Inc., Menlo Park Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
US6723340B2 (en) 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
CN1638741A (zh) 2002-01-03 2005-07-13 史密丝克莱恩比彻姆公司 新药物剂型及生产这种剂型的方法
GB0214013D0 (en) 2002-06-18 2002-07-31 Euro Celtique Sa Pharmaceutical product
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
IL166183A0 (en) 2005-01-06 2006-01-15 Yissum Res Dev Co Novel diagnostic and imaging techniques of the gi tract
JPWO2007010847A1 (ja) 2005-07-15 2009-01-29 キッセイ薬品工業株式会社 徐放製剤
WO2007072495A2 (en) 2005-11-03 2007-06-28 Sun Pharmaceutical Industries Limited Coated tablets having prolonged gastric retention
ATE489079T1 (de) 2005-12-29 2010-12-15 Osmotica Kereskedelmi Es Szolgaltata Kft Mehrschichtige tablette mit dreifacher freisetzungskombination
DK1981465T3 (en) 2006-01-18 2016-02-01 Intec Pharma Ltd METHOD FOR PRODUCING delivery devices FOR ORAL USE OF A MEANS
US20090304768A1 (en) 2006-02-15 2009-12-10 Intec Pharma Ltd Gastro-Retentive System for the Delivery of Macromolecules
WO2007106957A1 (en) 2006-03-21 2007-09-27 Laboratoires Smb S.A. Multiple units controlled-release floating dosage forms
US9579227B2 (en) 2006-03-29 2017-02-28 Eat Little Inc. Ingestible implement for weight control
JPWO2008087882A1 (ja) 2007-01-15 2010-05-06 キッセイ薬品工業株式会社 胃内滞留型レボドパ徐放性製剤
JP2011503048A (ja) 2007-11-08 2011-01-27 グラクソ グループ リミテッド 医薬製剤
CA2721493C (en) 2008-04-18 2017-11-28 Intec Pharma Ltd. Carbidopa/levodopa gastroretentive drug delivery
EP2133071A1 (en) 2008-06-09 2009-12-16 Université de la Méditerranée Process for making gastroretentive dosage forms
KR20110042366A (ko) 2008-08-18 2011-04-26 팀 아카데미 오브 파마슈티컬 사이언스 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용
WO2010035273A2 (en) 2008-09-29 2010-04-01 Intec Pharma Ltd. Novel gastroretentive delivery system
US20110066175A1 (en) 2009-05-07 2011-03-17 Rainbow Medical Ltd. Gastric anchor
WO2011048494A2 (en) 2009-10-19 2011-04-28 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
WO2011090724A2 (en) 2009-12-29 2011-07-28 Impax Laboratories, Inc. Gastroretentive solid oral dosage forms with lipid-based low-density excipient
WO2012006963A1 (zh) 2010-07-16 2012-01-19 Zhong Shuguang 在控释制剂中的聚合物增强剂
CN101919803A (zh) 2010-07-16 2010-12-22 钟术光 一种控释制剂
US9941319B2 (en) 2010-10-13 2018-04-10 Monolithic 3D Inc. Semiconductor and optoelectronic methods and devices
EP2635272A1 (en) 2010-11-01 2013-09-11 Intec Pharma Ltd. Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms
US20130072869A1 (en) 2011-09-15 2013-03-21 The Johns Hopkins University Intra-Gastric Timed-Release Drug Delivery System
CA2851765C (en) 2011-10-11 2017-08-15 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
KR101461332B1 (ko) 2013-08-02 2014-11-13 삼성전기주식회사 센서용 검출모듈 및 이를 구비하는 각속도 센서
US9016811B2 (en) 2013-08-05 2015-04-28 Concealment Solutions Inc. Apparatus for concealing household objects
WO2015083171A1 (en) 2013-12-05 2015-06-11 Tulip Medical Ltd. Retentive devices and systems for in-situ release of pharmaceutical active agents
CA2949372C (en) * 2014-06-02 2023-08-22 Teva Pharmaceutical Industries Ltd. Expandable gastroretentive dosage form
CA2951884A1 (en) 2014-06-11 2015-12-17 Massachusetts Institute Of Technology Residence structures and related methods
CA3007165A1 (en) 2015-12-02 2017-06-08 Clexio Biosciences Ltd. Device for preparing gastroretentive dosage forms
IL266377B2 (en) 2016-12-02 2023-10-01 Clexio Biosciences Ltd Stomach retention system
EP3720537A1 (en) * 2017-12-04 2020-10-14 Clexio Biosciences Ltd. Long acting gastric residence system

Similar Documents

Publication Publication Date Title
JP2021505241A5 (ja)
JP2019502892A5 (ja)
JP2019536800A5 (ja)
JP2017514639A5 (ja)
JP2018531290A5 (ja)
UY31114A1 (es) Anticuerpos humanizados contra el globulómero ab(20-42) y sus usos
JP2020531120A5 (ja)
JP2023021979A5 (ja)
CY1112511T1 (el) Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline)
JP2019514354A5 (ja)
MX2009012949A (es) Anticuerpos humanizados que enlazan a ab (1-42) globulomero y usos de los mismos.
EP3005993A3 (en) Gastric bypass system and method
JP2016508852A5 (ja)
JP2020534246A5 (ja)
JP2014519854A5 (ja)
CY1120240T1 (el) Απο του στοματος χορηγουμενο παρασκευασμα δισκιου ενωσης τετρακυκλινης
JP2019527311A5 (ja)
JP2014508098A5 (ja)
JP2017505825A5 (ja)
JP2009523456A5 (ja)
JP2017511372A5 (ja)
IL277024A (en) ", 5"-dimethoxybenzoyl-3'-amino-3'-deoxyadenosine-5'-triphosphates and their pharmaceutical uses
JP2019534285A5 (ja)
JP2019218304A5 (ja)
JPWO2020237172A5 (ja)